M&T Bank
IRMD icon

M&T Bank’s iRadimed IRMD Stock Holding History

M&T Bank’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$520K Buy
+5,400
New +$540K ﹤0.01% 1096

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's IRMD Position: Q1 2026 in Review

M&T Bank opened a new position in iRadimed (IRMD) in Q1 2026: 5,400 shares worth $520K. The stake represents ﹤0.01% of the portfolio and ranks #1096 among its holdings.

228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • M&T Bank held 5,400 shares of iRadimed worth $520K as of Q1 2026.
  • iRadimed was a new M&T Bank position in Q1 2026.
  • iRadimed made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1096 holding.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.